Arix Bioscience announced the formation of the LAB591, an academic “BRIDGE” collaboration with the Fred Hutchinson Cancer Research Center (“Fred Hutch”) and Evotec AG. LAB591 aims to accelerate research discoveries at Fred Hutch and leverage these discoveries to form new companies focused on cancer and infectious disease drug development. Arix, Evotec and Fred Hutch plan to jointly select promising LAB591 research projects from the Fred Hutch labs. After developing a r...